Tang Hsiao-Yuan, Fang Ping, Ward Patricia A, Schmitt Eric, Darilek Sandra, Manolidis Spiros, Oghalai John S, Roa Benjamin B, Alford Raye Lynn
Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas 77030, USA.
Am J Med Genet A. 2006 Nov 15;140(22):2401-15. doi: 10.1002/ajmg.a.31525.
Mutations in GJB2 are associated with hereditary hearing loss. DNA sequencing of GJB2 in a cohort of hearing impaired patients and a multi-ethnic control group is reported. Among 610 hearing impaired cases, 43 DNA sequence variations were identified in the coding region of GJB2 including 24 mutations, 8 polymorphisms, 3 unclassified variants (G4D, R127C, M163V), 1 controversial variant (V37I), and 7 novel variants (G12C, N14D, V63A, T86M, L132V, D159, 592_600delinsCAGTGTTCATGACATTC). Sixteen non-coding sequence variations were also identified among cases including the IVS1+1A>G mutation, 2 polymorphisms, and 13 novel variants. A diagnosis of GJB2-associated hearing loss was confirmed for 63 cases (10.3%). Heterozygous mutations were found in 39 cases (6.4%). Eleven cases carrying novel or unclassified variants (1.8 %) and 18 cases carrying the controversial V37I variant were identified (3%). In addition, 294 control subjects from 4 ethnic groups were sequenced for GJB2. Thirteen sequence variations in the coding region of GJB2 were identified among controls including 2 mutations, 6 polymorphisms, 2 unclassified variants (G4D, T123N), 1 controversial variant (V37I), and 2 novel variants (R127L, V207L). Nine sequence variations were identified among controls in the non-coding regions in and around GJB2 exon 2. Of particular interest among controls were the variability in carrier rates and ethnic stratification of alleles, and the complex genotypes among Asians, 47% of whom carried two to four sequence variations in the coding region of GJB2. These data provide new information about carrier rates for GJB2-based hearing loss in various ethnic groups and contribute to evaluation of the pathogenicity of the controversial V37I variant.
GJB2基因的突变与遗传性听力损失相关。本文报道了对一组听力受损患者和一个多民族对照组进行GJB2基因的DNA测序结果。在610例听力受损病例中,在GJB2基因的编码区鉴定出43个DNA序列变异,其中包括24个突变、8个多态性、3个未分类变异(G4D、R127C、M163V)、1个有争议的变异(V37I)和7个新变异(G12C、N14D、V63A、T86M、L132V、D159、592_600delinsCAGTGTTCATGACATTC)。在病例中还鉴定出16个非编码序列变异,包括IVS1+1A>G突变、2个多态性和13个新变异。确诊63例(10.3%)为GJB2相关的听力损失。39例(6.4%)发现杂合突变。鉴定出11例携带新的或未分类变异的病例(1.8%)和18例携带争议性V37I变异的病例(3%)。此外,对来自4个种族的294名对照者进行了GJB2基因测序。在对照者中,在GJB2基因的编码区鉴定出13个序列变异,包括2个突变、6个多态性、2个未分类变异(G4D、T123N)、1个有争议的变异(V37I)和2个新变异(R127L、V207L)。在GJB2外显子2及其周围的非编码区中,对照者中鉴定出9个序列变异。对照者中特别值得关注的是等位基因携带率的变异性和种族分层,以及亚洲人中的复杂基因型,其中47%的人在GJB2基因的编码区携带两到四个序列变异。这些数据提供了关于不同种族中基于GJB2的听力损失携带率的新信息,并有助于评估有争议的V37I变异的致病性。